	US 12,312,603 B2
	Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof
Nobuyuki Takakura, Osaka (JP); Hisamichi Naito, Osaka (JP); and Taku Wakabayashi, Osaka (JP)
Assigned to Osaka University, Osaka (JP)
Filed by Osaka University, Osaka (JP)
Filed on Jan. 26, 2024, as Appl. No. 18/424,597.
Application 18/424,597 is a division of application No. 16/763,938, granted, now 11,920,161, previously published as PCT/JP2018/042255, filed on Nov. 15, 2018.
Claims priority of application No. 2017-221955 (JP), filed on Nov. 17, 2017.
Prior Publication US 2024/0279616 A1, Aug. 22, 2024
Int. Cl. C12N 5/071 (2010.01); A61K 35/44 (2015.01); A61P 1/16 (2006.01); A61P 7/04 (2006.01); G01N 33/50 (2006.01)

CPC C12N 5/0692 (2013.01) [A61K 35/44 (2013.01); A61P 1/16 (2018.01); A61P 7/04 (2018.01); G01N 33/5073 (2013.01); C12N 2509/10 (2013.01)]

16 Claims

1. A cell population comprising mammalian cells that are positive for cell surface markers CD31, CD157 and CD200 and negative for CD45.